Basilea Pharmaceutica and Johnson and Johnson worked together on the drug for MRSA infections and after not meeting quality and monitoring standards with both the FDA and European Regulators, J and J says goodbye to Basilea and you are on your own, no more money. J and J conducted the trials...
The Medical Quack .... by Barbara Duck
The Medical Quack
Sun, Feb 21 2010
Filed under: Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, MRSA, Recalls, Legal Suits, Investments, CE Mark, Microsoft Tags, Johnson and Johson, Basilea Pharmaceutica